Form 8-K - Current report:
SEC Accession No. 0001104659-23-076136
Filing Date
2023-06-29
Accepted
2023-06-29 09:08:08
Documents
47
Period of Report
2023-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320045d1_8k.htm   iXBRL 8-K 70782
2 EXHIBIT 2.1 tm2320045d1_ex2-1.htm EX-2.1 728927
3 EXHIBIT 10.1 tm2320045d1_ex10-1.htm EX-10.1 67827
4 EXHIBIT 10.2 tm2320045d1_ex10-2.htm EX-10.2 98899
5 EXHIBIT 10.3 tm2320045d1_ex10-3.htm EX-10.3 25950
6 EXHIBIT 10.4 tm2320045d1_ex10-4.htm EX-10.4 219840
7 EXHIBIT 10.5 tm2320045d1_ex10-5.htm EX-10.5 108102
8 EXHIBIT 99.1 tm2320045d1_ex99-1.htm EX-99.1 33597
9 EXHIBIT 99.2 tm2320045d1_ex99-2.htm EX-99.2 55894
13 GRAPHIC tm2320045d1_ex99-2img001.jpg GRAPHIC 135746
14 GRAPHIC tm2320045d1_ex99-2img002.jpg GRAPHIC 316515
15 GRAPHIC tm2320045d1_ex99-2img003.jpg GRAPHIC 231190
16 GRAPHIC tm2320045d1_ex99-2img004.jpg GRAPHIC 164093
17 GRAPHIC tm2320045d1_ex99-2img005.jpg GRAPHIC 113221
18 GRAPHIC tm2320045d1_ex99-2img006.jpg GRAPHIC 173805
19 GRAPHIC tm2320045d1_ex99-2img007.jpg GRAPHIC 158216
20 GRAPHIC tm2320045d1_ex99-2img008.jpg GRAPHIC 84707
21 GRAPHIC tm2320045d1_ex99-2img009.jpg GRAPHIC 156562
22 GRAPHIC tm2320045d1_ex99-2img010.jpg GRAPHIC 181944
23 GRAPHIC tm2320045d1_ex99-2img011.jpg GRAPHIC 160626
24 GRAPHIC tm2320045d1_ex99-2img012.jpg GRAPHIC 81902
25 GRAPHIC tm2320045d1_ex99-2img013.jpg GRAPHIC 178795
26 GRAPHIC tm2320045d1_ex99-2img014.jpg GRAPHIC 162442
27 GRAPHIC tm2320045d1_ex99-2img015.jpg GRAPHIC 140588
28 GRAPHIC tm2320045d1_ex99-2img016.jpg GRAPHIC 75828
29 GRAPHIC tm2320045d1_ex99-2img017.jpg GRAPHIC 154291
30 GRAPHIC tm2320045d1_ex99-2img018.jpg GRAPHIC 148384
31 GRAPHIC tm2320045d1_ex99-2img019.jpg GRAPHIC 133400
32 GRAPHIC tm2320045d1_ex99-2img020.jpg GRAPHIC 81735
33 GRAPHIC tm2320045d1_ex99-2img021.jpg GRAPHIC 134143
34 GRAPHIC tm2320045d1_ex99-2img022.jpg GRAPHIC 159458
35 GRAPHIC tm2320045d1_ex99-2img023.jpg GRAPHIC 145300
36 GRAPHIC tm2320045d1_ex99-2img024.jpg GRAPHIC 144495
37 GRAPHIC tm2320045d1_ex99-2img025.jpg GRAPHIC 125416
38 GRAPHIC tm2320045d1_ex99-2img026.jpg GRAPHIC 148195
39 GRAPHIC tm2320045d1_ex99-2img027.jpg GRAPHIC 198944
  Complete submission text file 0001104659-23-076136.txt   7531860

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA immu-20230628.xsd EX-101.SCH 2959
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20230628_lab.xml EX-101.LAB 34240
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20230628_pre.xml EX-101.PRE 22359
41 EXTRACTED XBRL INSTANCE DOCUMENT tm2320045d1_8k_htm.xml XML 3595
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 231054640
SIC: 2834 Pharmaceutical Preparations